CIH Kharkiv City General Practice

Kharkiv 61172

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Remitting Multiple Sclerosis

Studies at this site

• A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis — Status unconfirmed